The necessity of cofactors in the pathogenesis of AIDS: A mathematical model

Journal of Theoretical Biology

Volumn 187, Issue 1, 1997, Pages 135-146

  Root Bernstein, Robert S ^a   Merrill, Stephen J ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MATHEMATICAL MODEL; PRIORITY JOURNAL; VIRUS PATHOGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031558224     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1997.0449     Document Type: Article

References (88)

1. ALKHATIB, G., COMBADIERE, C., BRODER, C. C., FENG, Y., KENNEDY, P. E., MURPHY, P. M. & BERGER, E. A. (1996). CC CKR5: a RANTES, MIP-1Alpha, MIP-1Beta receptor is a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
2. ARORA, P. K., FRIDE, E., PETITTO, J., WAGGIE, K. & SKOLNICK, P. (1990). Morphine-induced immune alteration in vivo. Cell. Immunol, 126, 343-353.
3. ASCHER, M. S. & SHEPPARD, H. W. (1988). AIDS as immune system activation: a model for pathogenesis. Clin. Exp. Immunol. 73, 165-167.
4. ASCHER, M. S., SHEPPARD, H. W. & KROWKA, J. F. (1995). AIDS as immune system activation: key questions that remain. In: Cell Activation and Apoptosis in HIV Infection (Andrieu, J.-M. & Lu, W., eds). pp. 203-210. New York: Plenum Press.
5. Assoku, R. K., Hazlett, C.A. & TIZARD, I. (1979). Immunosuppression in experimental African tyrpanosomiasis. Polyclonal B-cell activation and mytogenicity of trypanosome-derived saturated fatty acids. Int. Arch. Allergy Appl. Immunol. 59, 298-307.
6. BATTAGAY, M., MOSKOPHIDIS, D., RAHEMTULLA, A., HENGARTNER, H., MAK, T. W. & ZINKERNAGEL, R. M. (1994). Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J. Virol. 68, 4700-4704.
7. Bentwich, Z., Kalinkovicj, A. & WEISMAN, Z. (1995). Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol. Today 16, 187-191.
8. BLANCHARD, A. & MONTAGNIER, L. (1994). AIDS-associated mycoplasmas. Ann. Rev. Microbiol. 48, 687-712.
9. BRADY, M. T. & NG, A. (1987). Protection of neonates from transfusion-associated AIDS by the use of CMV-seronegative blood before availability of specific serologic tests for HTLV-III (HIV). Am. J. Perinatol. 4, 305-307.
10. BUIMOVICI-KLEIN, E., LANGE, M., ONG, K. R., GREICO, M. H. & COOPER, L. Z. (1988). Virus isolation and immune studies in a cohort of homosexual men. J. Med. Viol. 25, 371-385.
11. CAYZER, C. J. & DOBSON, C. (1983). Suppression of antibody production in mice given multiple concurrent infections with Nematosporioides dubius. Int. J. Parasitol. 13, 61-65.
12. CENTERS FOR DISEASE CONTROL, HIV/AIDS Surveillance Report, July 1991.
13. CHLEBOWSKI, R. T., GROSVENOR, M., LILLINGTON, L., SAYRE, J. & BEALL, G. (1994). Dietary intake and counseling, weight maintenance, and the course of HIV infection. J. Am. Diet. Assoc. 95, 428-432.
14. CLERICI, M. & SHEARER, G. M. (1994). The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15, 575-581.
15. CLERICI, M., GIORGI, J.V., CHOU, C.C., GUDEMAN, V.K., ZACK, J. A., GUPTA, P. et al. (1992). Cell-mediated immune response to human immunodeficiency virus (HIV) type I in seronegative homosexual men with recent sexual exposure to HIV-1. Infect. Dis. 165, 1012-1019.
16. COUTSOUIDIS, A., BOBAT, R. A., COOVADIA, H. M., KUHN, L., TSAI, W.-Y. & STEIN, Z. A. (1995). The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am. J. Public Health 85, 1076-1081.
17. DES JARLAIS, D. C., FRIEDMAN, S. R. & STONEBURNER, R. L. (1988). HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes and prevention. Rev. Infect. Dis. 10, 151-158.
18. DINEEN, J. K. & WAGLAND, B. M. (1966). The dynamics of the host-parasite relationship. V. Evidence for immunologic exhaustion in sheep experimentally infected with Haemonchus contortus. Parasitology 56, 665-677.
19. DOHERTY, P. C. (1993). Immune exhaustion: driving virus-specific CD8+ T cells to death. Trends Microbiol. 1, 207-209.
20. DREW, W. L., MILLS, J., LEVY, J. et al. (1985). Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann. Intern. Med. 103, 61-63.
21. EBBESEN, P. (1986). The global epidemic of AIDS. AIDS Res. 2(Suppl. 1), S23-28.
22. ESKILD, A., HEGER, B., BRUUN, J. N., FROLAND, S. S., IVERSEN, B., LOVIK, M. et al. (1994a). [Risk of AIDS in the Oslo HIV-cohort study. A comparison between homosexual men, intravenous addicts and heterosexual persons.] Tidsskr Nor Laegeforen 114, 2831-2834.
23. ESKILD, A., MAGNUS, P., SOHLBERG, C., KITTELSEN, P., OLVING J. H., TEIGE, B. & SKULLERUD, K. (1994b). Slow progression to AIDS in intravenous drug users infected with HIV in Norway. J. Epidemiol. Community Health 48, 383-387.
24. FONG, I. W., READ, S., WAINBERG, M. A., CHIA, W. K. & MAJOR, C. (1994). Alcoholism and rapid progression to AIDS after seroconversion. Clin. Infect. Dis. 19, 337-338.
25. GOMPERTS, E. D., DE BIASI, R. & DE VREKER, R. (1992). The impact of clotting factor concentrates on the immune system in individuals with hemophilia. Transfus. Med. Rev. 6, 44-54.
26. + lymphocytes. J. Immunol. 142, 773-780.
27. GROB, P. J., HOLCH, M. & BRUNNER, W. (1987). [Post-traumatic/ postoperative immune deficiency syndrome]. Schweiz. Med. Wochenschr. 117, 471-480.
28. GROENBLADH, L. & GUNNE, L. (1989). Methadone-assisted rehabilitation of Swedish heroin addicts. Drug Alcohol Depend. 24, 31-37.
29. HENRY, K., CAMPBELL, S., JACKSON, B. et al. (1990). Longterm follow-up of health care workers with worksite exposure to human immunodeficiency virus. JAMA 263, 1765-1766.
30. HILGARTNER, M. W., BUCKLEY, J. D., OPERSKALSI, E. A., PIKE, M. C. & MOSELY, J. W. (1993). Purity of factor VIII concentrates and serial CD4 counts. Lancet 341, 1373-1374.
31. HOOD, A. F., FARMER, E. R. & WEISS, R. A. (1982). Clinical conferences at The Johns Hopkins Hospital: Kaposi's sarcoma. Johns Hopkins Medical J. 151, 222-230.
32. JACOBSON, M. A. (1994). Current management of cytomegalovirus disease in patients with AIDS. Res. Hum. Retroviruses 10, 917-923.
33. JOHNSON, E. J., SIZEMORE, R. C. & GOTTLIEB, A. A. (1995). HIV retrotransposon activity and the immunopathogenesis of AIDS. Trends Microbiol. 3, 115-117.
34. KALLENIUS, G., HOFFNER, S. E. & SVENSON, S. B. (1989). Does vaccination with bacille Calmette-Guerin protect against AIDS? Rev. Infect. Dis. 11, 349-351.
35. KIM, H. C., NAHUM, K., RASKA, K. JR, GOCKE, D. J., KOSMIN, M., KARP, G. I. & SAIDI, P. (1987). Natural history of acquired immunodeficiency syndrome in hemophilic patients. Am. J. Hematol. 24, 169-176.
36. KNOX, K. K. & CARRIGAN, D. R. (1996). Active HHV-6 infection in the lymph nodes of HIV-infected patients: in vitro evidence that HHV-6 can break HIV latency. J. Acquir. Imm. Defic. Syndr. Hum. Retrovir. 11, 370-378.
37. KREISS, J. K., COOMBS, R., PLUMMER, F., HOLMES, K. K., NIKORA, B., CAMERON, W. et al. (1989). Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J. Infect. Dis. 160, 340-344.
38. LAUENER, R. P., HÜTTNER, S., BUISSON, M., HOSSLE, J. P., ALBISETTI, M., SEIGNEURIN, J.-M. et al. (1995). T-cell death by apoptosis in vertically human immunodeficiency virus-infected children coincides with expansion of CD8+ /interleukin-2 receptor-/ HLA-DR+ T cells: Sign of a possible role for herpes viruses as cofactors? Blood 86, 1400-1407.
39. LAYNE, S. P., MERGES, M. J., DEMBO, M., SPOUGE, J. L., CONLEY, S. R., MOORE, J. P. et al. (1992). Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189, 695-714.
40. LAZZARIN, A., MELLA, L., TROMBINI, M., UBERTI-FOPPA, C., FRANZETTI, F., MAZZONI, G. & GALLI, M. (1984). Immunological status in heroin addicts: effects of methadone maintenance treatment. Drug Alcohol Depend. 13, 117-123.
41. LEMAITRE, M., GUETARD, D., HENIN, Y., MONTAGNIER, L. & ZERIAL A. (1990). Protective activity of tetracycline3 analogs against the cytopathic effect of the human immunodeficiency virus in CEM cells. Res. Virol. 141, 5-10.
42. Lo, S.-C., DAWSON, M. S., WONG, D. M. et al. (1989). Identification of Mycoplasma incognitus infection in patients with AIDS: An immunohistochemical, in situ hybridization and ultrastructural study. Amer. J. Trop. Med. Hyg. 41 601-616.
43. Lo, S.-C., HAYES, M. M., WANG, R. Y., PIERCE, P. F., KOTANI, H. & SHIH, J. W. (1991a). Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 338, 1415-1418.
44. Lo, S.-H., TSAI, S., BENISH, J. R. et al. (1991b). Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science 251, 1074-1076.
45. Lusso, P., ENSOLI, B., MARKHAM, P. D. et al. (1989. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature 337, 370-373.
46. Lusso, P., VERONESE, F. M., ENSOLI, B. et al. (1990). Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247, 848-852.
47. Lusso, P. & GALLO, R. C. (1995). Human herpesvirus 6 in AIDS. Immunol. Today 16, 67-71.
48. MANNUCCI, P. M., GRINGERI, A., DE BIASI, R., BAUDO, F., MORFINI, M. & CIAVERELLA, N. (1992). Immune status of asymptomatic HIV-infected haemophiliacs: randomized, prospective, two-year comparison of treatment with high-purity or an intermediate-purity factor VIII (FVIII). Thromb. Haemost. 67, 310-313.
49. MARKHAM, A. & FAULDS, D. (1994). Ganciclovir. An update of its therapeutic use in cytomegalovirus infection. Drugs 48, 455-484.
50. MEDLEY, G. F., ANDERSON, R. M., Cox, D. R. & BILLARD, L. (1987). Incubation period of AIDS in patients infected via blood transfusion. Nature 328, 719-720.
51. McLEAN, A. R., NOWAK, M. A. (1992). Models of interactions between HIV and other pathogens. J. theor. Biol. 155, 69-86.
52. MERRILL, S. J. & RADKE, R. J. (1997a). A stochastic model of the generation of diversity in HIV infection. J. Immunol. Methods: Comp Models in Immunol. (in press).
53. MERRILL, S. J., ROOT-BERNSTEIN, R. S. (1997b). A model of the role of cofactors in the initiation and development of AIDS. Canadian Appl. Math. Quarterly. (in press).
54. MICHALANY, J., MATTOS, A. L., MICHALANY, N. S., FILIE, A. C. & MONTEZZO, L. C. (1987). Acquired immune deficiency syndrome (AIDS) in Brazil. Necropsy finding. Ann. Pathol. 7, 15-24.
55. MOSKOPHIDIS, D., LECHNER, F., PIRCHER, H. & ZINKERNAGEL, R. M. (1993). Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758-761.
56. Moss, A. R., BACCHETTI, P., OSMOND, D., KRAMPF, W., CHAISSON, R. E., STITES D. et al. (1988). Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br. Med. J. Clin. Res. Ed. 296, 745-750.
57. MULLER, H. & TAKESHITA, M. (1991). [Immunohistochemical characterization of HIV- and non-HIV-associated lymph node tuberculosis.] Verh. Dtsch. Ges. Pathol. 75, 166-170.
58. MULTICOHORT ANALYSIS PROJECT WORKSHOP. (1994). Immunologic markers of AIDS progression: Consistency across five HIV-infected cohorts. AIDS 8, 911-921.
59. NATIONAL RESEARCH COUNCIL) (1993). AIDS: The Social Impact of AIDS. National Academy of Sciences, Washington, D.C.
60. NOWAK, M. A., ANDERSON, R. M., MCLEAN, A. R., WOLFS, T. F. W., GOODSMIT, J. & MAY, R. M. (1991). Antigenic diversity thresholds and the development of AIDS. Science 254, 963-969.
61. O'BRIEN, W. A., GROVIT-FERBAS, K., NAMAZI, A., OVCAK-DERZIC, S., WANG, H.-J., PARK, J., YERAMIAN, C., MAO, S.-H. & ZACK, J. A. (1995). Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 86, 1082-1089.
62. PETERMAN, T. A., STONEBURNER, R. L., ALLEN, J. R., JAFFE, H. W. & CURRAN, J. W. (1988). Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 259, 55-59.
63. QUINN, C., PIOT, P., MCCORMICK, J. B. et al. (1987). Serologic and immunologic studies in patients with AIDS in North America and Africa. JAMA 257, 2617-2621.
64. ROGERS, M. F., THOMAS, P. A., STARCHER, E. T., NOA, M. C., BUSH, T. J. & JAFFE, H. W. (1987). Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982-1985. Pediatrics 79, 1008-1014.
65. ROOT-BERNSTEIN, R. S. (1990). Do we know the cause(s) of AIDS? Perspectives in Biology and Medicine 33, 480-500.
66. ROOT-BERNSTEIN, R. S. (1993). Rethinking AIDS. The Tragic Cost of Premature Consensus. New York: Free Press.
67. ROOT-BERNSTEIN, R. S. & HOBBS, S. H. (1993). Does HIV "piggyback" on CD4-like surface proteins of sperm, viruses, and bacteria? Implications for co-transmission, cellular tropism and the induction of autoimmunity in AIDS. J. theor. Biol. 160, 249-264.
68. ROOT-BERNSTEIN, R. S. (1995). Five myths about AIDS that have misdirected research and treatment. Genetica 95, 111-132.
69. ROOT-BERNSTEIN, R. S. & DEWITT, S. H. (1995). Semen alloantigens and lymphocytotoxic antibodies in AIDS and ICL. Genetica 95, 133-156.
70. SABIN, C. A., PHILLIPS, A. N., LEE, C. A., JANOSSY, G., EMERY, V. & GRIFFITHS, P. D. (1995). The effect of CMV infection on the progression of human immunodeficiency virus disease in a cohort of haemophilic men followed for up to 13 years from seroconversion. Epidemiol. Infect. 114, 361-372.
71. SAPPEY, C., LECLERCQ, P., COUDRAY, C., FAURE, P., MICOUD, M. & FAVIER, A. (1994). Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clin. Chim. Acta 230, 35-42.
72. SARNGADHARAN, M. G. & MARKHAM, P. D. (1987). The role of human T-lymphotropic retroviruses in leukemia and AIDS. In: AIDS - Acquired Immune Deficiency Syndrome - and Other Manifestations of HIV Infection (Wormser, G. P., ed.) p. 197. Park Ridge, NJ: Noyes Publications.
73. SJAMSOEDIN-VISSER, L. J., HEIJNEN, C. J., ZEGERS, B. J. & STOOP, J. W. (1988). Defective T suppressor-inducer cell function in human immune deficiency virus-seropositive hemophilia patients. Blood 72, 1474-1477.
74. SONNABEND, J. A. (1989). AIDS: An explanation for its occurance among homosexual men. In: AIDS and Infections of Homosexual Men. 2nd edn (Ma, P. and Armstrong, D., eds) pp. 449-470. Boston: Butterworths.
75. SQUINTO, S. P., MONDAL, D., BLOCK, A. L. & PRAKASH, O. (1990). Morphine-induced transactivation of HIV-1 LTR in human neuroblastoma cells. AIDS Res. Hum. Retroviruses 6, 1163-1168.
76. STANLEY, S. K., OSTROWSKI, M. A., JUSTEMENT, J. S., GANTT, K., HEDAYATI, S, MANNIX, M. et al. (1996). Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type I. N. Engl. J. Med. 334, 1222-1230.
77. STEWART, G. T. (1995). The epidemiology and transmission of AIDS: a hypothesis linking behavior and biological determinants to time, person and place. Genetica 95, 90-110.
78. SUTTMANN, U., OCKENGA, J., SELBERG, O., HOOTESTRAAT, L., DEICHER, H. & MULLER, M. J. (1995). Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J. Acquir. Imm. Defic. Synd. Hum. Retrovir. 8, 239-246.
79. TORIAN, L. V., WEISFUSE, I. B., MAKKI, H. A., BENSON, D. A., DICAMILLO, L. M. & TORIBIO, F. E. (1995). Increasing HIV-1 seroprevalence associated with genital ulcer disease, New York City, 1990-1992. AIDS 9, 177-181.
80. URNOVITZ, H. B., CLERICI, M., SHEARER, G. M., GOTTFRIED, T. D., ROBINSON, D. J., LUTWICK, L. I. et al. (1993). HIV-1 antibody serum negativity with urine positivity. Lancet 342, 1458-1459.
81. WEBER, R., LEDERGERBER, W., OPRAVIL, M., SIEGENTHALER, W. & LÜTHY, R. (1990). Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br. Med. J. 301, 1361-1365.
82. WEBSTER, A., LEE, C. A., COOD, D. G., GRUNDY, J. E. et al. (1989). Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet ii, 63-66.
83. WEISS, R. A. (1993). How does HIV cause AIDS? Science 260, 1273-1279.
84. WEYER, J. & EGGERS, H. J. (1990). On the structure of the epidemic spread of AIDS: the influence of an infectious coagent. Zbl. Bakt. 273, 52-67.
85. WOLFS, T. F., WOLF, F., BREEDERVELD, C., SJAMSEJOEDIN-VISSER, L. J., ROOS, M., BAKKER, M. & GOUDSMIT, J. (1989). Low AIDS attack rate among Dutch haemophiliacs compared to homosexual men: a correlate of HIV antigenaemia frequencies. Vox Sang 57, 127-132.
86. ZACH, J. A., CANN, A. J., LUGO, J. P. & CHEN, I. S. Y. (1988). AIDS virus production from infected peripheral blood T cells following HTLV-I-induced mitogenic stimulation. Science 240, 1026-1029.
87. ZACH, J. A., ARRIGO, S. J., WEITSMAN, S. R., GO, A. S., HAISLIP, A. & CHEN, I. S. Y. (1990). HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222.
88. ZAGURY, D., BERNARD, J., LEONARD, R., CHEYNIER, R., FELDMAN, M., SARIN, P. S. & GALLO, R. C. (1986). Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T-cell depletion in AIDS. Science 231, 850-853.